Actively Recruiting
Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China
Led by Jiangsu Taizhou People's Hospital · Updated on 2026-05-28
2500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Atrial fibrillation (AF) is a common irregular heart rhythm in older adults and is linked to a higher risk of heart failure (HF) and other heart-related problems. This research focuses on screening for HF among elderly patients with AF living in rural areas of China and aims to observe how HF and related heart conditions progress over time in these patients. This observational study will include at least 2,500 participants aged 65 to 80 years who have confirmed AF and live in rural China. Participants will undergo screening for heart failure using NT-proBNP blood tests and echocardiograms. Additional data will be collected, including electrocardiogram signals, seismocardiography, voice recordings, and demographic information. After initial assessments, participants will be followed up every three months to monitor the development of heart failure and any adverse cardiovascular events. During the study, participants will have regular evaluations every three months to track their heart health and changes in their condition. The researchers will use the collected data to understand the incidence and progression of heart failure among elderly rural patients with AF. The study will last for an average of three years, with a focus on a combined measure of heart-related health outcomes over this period.
CONDITIONS
Brief Title
Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Permanent resident with local household registration in rural China
- Aged between 65 and 80 years
- Confirmed diagnosis of atrial fibrillation by electrocardiogram or specialist-issued certificate
- Willing to participate in heart failure screening
- Able to understand study procedures and provide written informed consent
You will not qualify if you...
- Expected life expectancy less than 3 months
- Severe renal insufficiency (creatinine clearance less than 30 ml/min) or on dialysis
- Cardiac insufficiency due to treatable causes like hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease
- Indications for pacemaker implantation without having undergone implantation
- Chronic obstructive pulmonary disease with type II respiratory failure
- Patients with mental illnesses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 3 years
Participants with atrial fibrillation are observed over time to monitor health outcomes.
Trial Site Locations
Total: 1 location
1
Department of Cardiology
Taizhou, Jiangsu, China, 225300
Actively Recruiting
Research Team
C
Chuanmeng Zhang, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here